Stay updated on Biomarker-Based Therapies in Early Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Biomarker-Based Therapies in Early Lung Cancer Clinical Trial page.

Latest updates to the Biomarker-Based Therapies in Early Lung Cancer Clinical Trial page
- Check3 days agoChange DetectedThe page now shows a site-wide notice about government funding and the NIH Clinical Center status, and the record version has been updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check10 days agoChange DetectedUI enhancements on the history page include a new 'Show glossary' option and color-coded highlights for changes (green for additions, red for deletions) with an updated revision label (v3.4.0). The 'No FEAR Act Data' label was added/standardized and the older 'Revision: v3.3.4' reference is removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedTwo new revision entries dated 2026-01-12 and 2026-01-09 were added to the Record History with Revision: v3.3.4, and the 2025-12-15 entry for v3.3.3 was removed.SummaryDifference0.2%

- Check45 days agoChange DetectedThe page history now includes Revision: v3.3.3, and the HHS Vulnerability Disclosure link and Revision: v3.3.2 entry were removed.SummaryDifference0.1%

- Check53 days agoChange DetectedNew 'Study Status' entry added on 2025-12-12 (version 68). A deletion occurred on 2025-11-17 in the page history.SummaryDifference0.2%

- Check67 days agoChange DetectedMinor site revision from v3.3.1 to v3.3.2 appears in the footer; no substantive changes to study records or page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Biomarker-Based Therapies in Early Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Biomarker-Based Therapies in Early Lung Cancer Clinical Trial page.